MedPath

Cognitive-Behavioural Therapy as a Preventive Treatment for Post Traumatic Stress Disorder

Not Applicable
Terminated
Conditions
Post Traumatic Stress Disorder
Interventions
Behavioral: Modified prolonged exposure therapy
Behavioral: Attention control
Registration Number
NCT03116165
Lead Sponsor
Karolinska Institutet
Brief Summary

This study will examine the use of modified prolonged exposure therapy in trauma patients recently exposed to trauma in an emergency room to prevent the onset of post-traumatic stress disorder.

Detailed Description

This study investigates if prolonged exposure is an effective treatment in reducing PTSD symptoms people who have recently experienced trauma. The study will also investigate predictive markers of PTSD, moderators of successful treatment and health economic aspects of the intervention.

Participants will first undergo an evaluation session that will include an interview (Immediate Stress Reaction Checklist) and questionnaires. Participants will subsequently be randomly assigned to receive either modified prolonged exposure therapy or attention control, starting the assigned intervention immediately. Participants in each arm will receive three weekly treatment sessions. Treatment will involve psychoeducation about common reactions to trauma, imaginal exposure (revisiting memories of a recent trauma out loud with a therapist and audio-recording these for review at home), exposure in vivo and breathing retraining. All participants will undergo assessments 2, 6 (primary endpoint) and 12 months after the intervention by blinded assessors. Patients unable to come to the clinic for follow-up assessments will be interviewed via telephone or skype. Source data will be quality monitored by an independent party (Karolinska trial alliance) according to the Helsinki Declaration.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
352
Inclusion Criteria
  • Presenting to the emergency department at the Karolinska University hospital Solna in the past 72 hours before the intervention
  • Meets diagnostic criterion A for post-traumatic stress disorder in the fifth version of Diagnostic and Statistical Manual of Mental Disorders, DSM-5
Read More
Exclusion Criteria
  • Do not want to participate in the study
  • Ongoing intoxication (e.g. severe alcohol intoxication)
  • Other serious psychiatric comorbidity that demands attention (e.g. manic episode, acute suicidal ideation)
  • Not oriented
  • Not having a memory ot the tramatic event
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Modified prolonged exposure therapyModified prolonged exposure therapyParticipants will receive three sessions of modified prolonged exposure therapy.
Attention controlAttention controlParticipants will receive three sessions of supportive counselling and psychoeducation
Primary Outcome Measures
NameTimeMethod
CLINICIAN-ADMINISTERED PTSD SCALE for Diagnostic and Statistical Manual of Mental Disorders-5 (CAPS)Change 2-, 6- (primary endpoint) and 12 months after intervention

Clinical interview that gives a continuous measure of PTSD severity and dichotomous diagnosis of PTSD

Secondary Outcome Measures
NameTimeMethod
PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders-5 (PCL-5)Change 2-, 6- (primary endpoint) and 12 months after intervention

Self-report questionnaire for the assessment of PTSD severity

Montgomery Åsberg Depression Rating Scale - Self-report (MADRS-S)Change from baseline to 2, 6 (primary endpoint) and 12 months after intervention

Self-report questionnaire for the assessment of severity of depression

Intrusion diaryChange at week 1, week 2 and week 3

A self-report diary on number of intrusions

Trimbos Institute of costs in psychiatry (TIC-P)Measured at 6 (primary endpoint) months after the intervention

Self-report measure on societal costs

Euroqol (EQ-5D)Measured 6 months after intervention

Measure of general health and quality of life

WHO Disability Assessment Schedule (WHODAS)Change 2-, 6- (primary endpoint) and 12 months after intervention

Measure of general health and function

Insomnia Severity Index (ISI)Change 2-, 6- (primary endpoint) and 12 months after intervention

Self-report questionnaire regarding insomnia

Adverse eventsChange 2-, 6- (primary endpoint) and 12 months after intervention

Measure of number adverse events

Subjective unit of distress scale (SUD)Change at week 1, week 2 and week 3

Ratings of distress

Multidimensional Scale of Perceived Social Support (MSPSS)Change 2-, 6- (primary endpoint) and 12 months after intervention

A measure to assess for social support

Trial Locations

Locations (1)

Karolinska Institutet

🇸🇪

Stockholm, Sweden

© Copyright 2025. All Rights Reserved by MedPath